Announcements Trials
Browse Landscape

Phase

Phase NA 14Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lymphedema 1Breast Neoplasms 1

Interventions

pembrolizumab 60Carboplatin 60Paclitaxel 51Magnetic Resonance Spectroscopy 42Specimen Handling 41Cisplatin 41Gemcitabine 34Bevacizumab 31Docetaxel 30Leucovorin 27Doxorubicin 27Fluorouracil 26Dexamethasone 25Cyclophosphamide 25Pemetrexed 23Radiotherapy 22Radiation 22Oxaliplatin 22Etoposide 21durvalumab 20Nivolumab 20Vincristine 19Taxes 19Rituximab 19Irinotecan 19Prednisone 18Letrozole 18Capecitabine 17Lenalidomide 16Immunoglobulin G 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Early Intervention, Educational × 30 days × Clear all
NCT00376597 2026-05-18

Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection

Alliance for Clinical Trials in Oncology

Phase 3 Completed
568 enrolled 7 charts
Breast

Breast Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡